Grand Biotek Inc.: 2026 Q1 EPS NT$-0.36
NQ Score
0/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Grand Biotek Inc. announced its financial results for the first quarter of 2026, reporting a basic EPS of NT$-0.36, operating revenue of NT$6 million, and net loss after tax of NT$23 million. This indicates the company is operating at a loss.